These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22389179)

  • 21. Classical neurotransmitters and neuropeptides involved in major depression: a review.
    Werner FM; Coveñas R
    Int J Neurosci; 2010 Jul; 120(7):455-70. PubMed ID: 20583898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of neuropeptide systems in schizophrenia: human studies.
    Cáceda R; Kinkead B; Nemeroff CB
    Int Rev Neurobiol; 2007; 78():327-76. PubMed ID: 17349866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of animal models of alcohol-related behavior.
    Crabbe JC
    Handb Clin Neurol; 2014; 125():71-86. PubMed ID: 25307569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of environmental manipulations in genetically targeted animal models of affective disorders.
    Renoir T; Pang TY; Hannan AJ
    Neurobiol Dis; 2013 Sep; 57():12-27. PubMed ID: 22525570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human and mouse model cognitive phenotypes in Down syndrome: implications for assessment.
    Edgin JO; Mason GM; Spanò G; Fernández A; Nadel L
    Prog Brain Res; 2012; 197():123-51. PubMed ID: 22541291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of two repeated restraint stress paradigms on hypothalamic-pituitary-adrenal axis habituation, gonadal status and central neuropeptide expression in adult male rats.
    Gray M; Bingham B; Viau V
    J Neuroendocrinol; 2010 Feb; 22(2):92-101. PubMed ID: 20002965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neurobiology of alcohol withdrawal inhibitory and excitatory neurotransmitters].
    Eşel E
    Turk Psikiyatri Derg; 2006; 17(2):129-37. PubMed ID: 16755413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy.
    Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR
    Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stress and epilepsy: multiple models, multiple outcomes.
    Sawyer NT; Escayg A
    J Clin Neurophysiol; 2010 Dec; 27(6):445-52. PubMed ID: 21076337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety.
    Thorsell A
    Exp Biol Med (Maywood); 2010 Oct; 235(10):1163-7. PubMed ID: 20881320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining research approaches to advance our understanding of drug addiction.
    van den Bree MB
    Curr Psychiatry Rep; 2005 Apr; 7(2):125-32. PubMed ID: 15802089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of neuropeptides in vivo and open questions for current and upcoming fluorescent sensors for neuropeptides.
    Inutsuka A; Ino D; Onaka T
    Peptides; 2021 Feb; 136():170456. PubMed ID: 33245950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-species molecular dissection across alcohol behavioral domains.
    Farris SP; Riley BP; Williams RW; Mulligan MK; Miles MF; Lopez MF; Hitzemann R; Iancu OD; Colville A; Walter NAR; Darakjian P; Oberbeck DL; Daunais JB; Zheng CL; Searles RP; McWeeney SK; Grant KA; Mayfield RD
    Alcohol; 2018 Nov; 72():19-31. PubMed ID: 30213503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studying the neurobiology of stimulant and alcohol abuse and dependence in genetically manipulated mice.
    Stephens DN; Mead AN; Ripley TL
    Behav Pharmacol; 2002 Sep; 13(5-6):327-45. PubMed ID: 12394407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.
    Bell RL; Hauser S; Rodd ZA; Liang T; Sari Y; McClintick J; Rahman S; Engleman EA
    Int Rev Neurobiol; 2016; 126():179-261. PubMed ID: 27055615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity of alcohol use disorder: understanding mechanisms to advance personalized treatment.
    Litten RZ; Ryan ML; Falk DE; Reilly M; Fertig JB; Koob GF
    Alcohol Clin Exp Res; 2015 Apr; 39(4):579-84. PubMed ID: 25833016
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetics of alcohol and other abused drugs.
    Crabbe JC; Phillips TJ
    Drug Alcohol Depend; 1998; 51(1-2):61-71. PubMed ID: 9716930
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular genetics of neurotransmitters and neuropeptides involved in Internet use disorders including first insights on a potential role of hypothalamus' oxytocin hormone.
    Sindermann C; Sariyska R; Elhai JD; Montag C
    Handb Clin Neurol; 2021; 182():389-400. PubMed ID: 34266607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promising pharmacogenetic targets for treating alcohol use disorder: evidence from preclinical models.
    Rinker JA; Mulholland PJ
    Pharmacogenomics; 2017 Apr; 18(6):555-570. PubMed ID: 28346058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.